Sinopharm

Sinopharm is a Chinese pharmaceutical company, officially known as the China National Pharmaceutical Group Corporation. It is one of the largest healthcare companies in China, with a wide range of products and services, including pharmaceuticals, healthcare services, and biotechnology research and development.

History

Sinopharm was established in 1998 and has since grown to become a leading player in China's healthcare industry. The company's growth has been driven by a combination of organic growth and strategic acquisitions.

Products and Services

Sinopharm offers a wide range of products and services, including:

• Pharmaceuticals: Sinopharm produces a wide range of pharmaceutical products, including both prescription and over-the-counter medications. The company's pharmaceutical portfolio includes drugs for a variety of conditions, including cardiovascular diseases, infectious diseases, and cancer.

• Healthcare Services: Sinopharm operates a network of hospitals and clinics across China. These facilities provide a range of healthcare services, from routine check-ups to specialized treatments.

• Biotechnology Research and Development: Sinopharm is also involved in biotechnology research and development. The company's R&D efforts are focused on developing new drugs and treatments for a variety of diseases.

COVID-19 Vaccine

Sinopharm has been involved in the development of a COVID-19 vaccine. The company's vaccine has been approved for use in several countries, including China, the United Arab Emirates, and Bahrain.

See Also

• Pharmaceutical industry in China
• COVID-19 vaccine
• Healthcare in China

References

Sinopharm Resources
Latest articles Most recent articles Ongoing trials	Wikipedia